Changeflow GovPing Pharma & Drug Safety Antimicrobial Agents and Compositions Patent
Routine Notice Added Final

Antimicrobial Agents and Compositions Patent

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Therapeutics (A61P)
Published March 25th, 2026
Detected April 2nd, 2026
Email

Summary

European Patent Office published patent application EP4031128A1 for Koda Therapeutics LLC, covering antimicrobial agents and compositions and uses thereof. The patent application lists three inventors and contains IPC classifications related to pharmaceutical compounds. Designated states include all EPC contracting states across Europe.

What changed

The EPO published European patent application EP4031128A1 for Koda Therapeutics LLC, covering antimicrobial agents and compositions for therapeutic use. The application identifies inventors Gerald S. Jones Jr., Joseph P. St. Laurent, and Scott A. Goodrich, with IPC classifications including A61K 31/34, A61K 31/345, A61K 31/664, A61P 31/04, C07D 307/34, and C07D 307/36.

This is a routine patent publication granting no new compliance obligations. Pharmaceutical companies and drug manufacturers should review this patent when conducting Freedom to Operate analyses for antimicrobial compounds. No action is required for general compliance purposes.

Source document (simplified)

← EPO Patent Bulletin

ANTIMICROBIAL AGENTS AND COMPOSITIONS AND USES THEREOF

Publication EP4031128A1 Kind: A1 Mar 25, 2026

Applicants

Koda Therapeutics, LLC

Inventors

JONES, Gerald S., Jr., ST. LAURENT, Joseph P., GOODRICH, Scott A.

IPC Classifications

A61K 31/34 20060101AFI20231107BHEP A61K 31/345 20060101ALI20231107BHEP A61K 31/664 20060101ALI20231107BHEP A61P 31/04 20060101ALI20231107BHEP C07D 307/34 20060101ALI20231107BHEP C07D 307/36 20060101ALI20231107BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

Antimicrobial Agents and Compositions and Uses Thereof

Classification

Agency
EPO
Published
March 25th, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP4031128A1

Who this affects

Applies to
Pharmaceutical companies Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent publication Pharmaceutical patents
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Therapeutics (A61P) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.